Ohr Pharmaceutical Inc. (OHRP)

0.20
NASDAQ : Health Technology
Prev Close 0.21
Day Low/High 0.19 / 0.21
52 Wk Low/High 0.18 / 2.18
Avg Volume 492.60K
Exchange NASDAQ
Shares Outstanding 56.21M
Market Cap 11.71M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

OHRP EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ohr Pharmaceutical, Inc. And A Lead Plaintiff Deadline Of April 16, 2018

OHRP EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Ohr Pharmaceutical, Inc. And A Lead Plaintiff Deadline Of April 16, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Ohr Pharmaceutical, Inc.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Ohr Pharmaceutical, Inc. Investors And Sets A Lead Plaintiff Deadline Of April 16, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Ohr Pharmaceutical, Inc. Investors And Sets A Lead Plaintiff Deadline Of April 16, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Ohr Pharmaceutical, Inc.

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Ohr Pharmaceutical, Inc. Shareholders And A Lead Plaintiff Deadline Of April 16, 2018 (OHRP)

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Ohr Pharmaceutical, Inc. Shareholders And A Lead Plaintiff Deadline Of April 16, 2018 (OHRP)

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ohr Pharmaceutical, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm

OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against OHR Pharmaceutical, Inc.

OHRP INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Ohr Pharmaceutical, Inc. And A Lead Plaintiff Deadline Of April 16, 2018

OHRP INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Ohr Pharmaceutical, Inc. And A Lead Plaintiff Deadline Of April 16, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Ohr Pharmaceutical, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint To Recover Losses Suffered By Ohr Pharmaceutical, Inc. Investors And Sets A Lead Plaintiff Deadline Of April 16, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint To Recover Losses Suffered By Ohr Pharmaceutical, Inc. Investors And Sets A Lead Plaintiff Deadline Of April 16, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Ohr Pharmaceutical, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

The Klein Law Firm Reminds Investors Of An Investigation Regarding Possible Violations Of Federal Securities Laws By Ohr Pharmaceutical, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Regarding Possible Violations Of Federal Securities Laws By Ohr Pharmaceutical, Inc.

The Klein Law Firm announces the commencement of an investigation of Ohr Pharmaceutical, Inc.

OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm

OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against OHR Pharmaceutical, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Ohr Pharmaceutical, Inc. (OHRP)

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Ohr Pharmaceutical, Inc. (OHRP)

The Klein Law Firm announces the commencement of an investigation of Ohr Pharmaceutical, Inc.

OHRP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Ohr Pharmaceutical, Inc.

OHRP INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Ohr Pharmaceutical, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Ohr Pharmaceutical, Inc.

OHRP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Ohr Pharmaceutical, Inc.

OHRP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Ohr Pharmaceutical, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings

Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings

Management to Host a Conference Call and Webcast at 5:00pm Eastern Time Today

Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings

Management to Host a Conference Call and Webcast at 5:00pm Eastern Time Today